retatrutide dosing phase 2 trial Guide for Researchers retatrutide dosing phase 2 trial

Weight changes from GLP-1 therapy may require adjustment of levothyroxine doses, necessitating close thyroid function monitoring

Historically, a physician could decide that he or she wanted to treat a patient with a certain drug and give it in a certain route of administration

Drug Safety

[DOI] [PMC free article] [PubMed] [Google Scholar] 29

In their questionnaire, which was used on every platorm, 98% asked about medical conditions, 93.9% asked about medications and allergies, and only 55.1% asked about eating disorder history

It can, however, also cause a reduction in lean muscle mass due to loss of appetite and consequent changes in nutritional intake